Donald Gleason Conference on Prostate and Urologic Cancers
Expert faculty share updates and best practices to advance our collective knowledge related to early diagnosis, proper staging, and effective treatment of urologic cancers. View agenda.
This conference is ideal for urologists, medical oncologists, radiation oncologists, nephrologists, physician assistants, advanced practice nurses, and all healthcare professionals who seek to gain greater insights into the effective diagnosis, management, and treatment of urologic cancers.
Following completion of this activity, learners should be better able to:
- Identify new approaches for diagnosis and treatment of urologic cancers.
- Describe the latest therapeutic interventions for urologic cancers.
- Describe emerging concepts in treatment of advanced urologic cancers.
- Explain the biology of urologic cancers.
- Discuss with patients the risks and benefits of new and evolving treatment options for urologic cancers.
- C. Richard Choo, MD, Mayo Clinic
- Dave DeGraff, PhD, Penn State College of Medicine
- Arkadiusz Dudek, MD, PhD, University of Illinois College of Medicine at Chicago
Additional confirmed speakers include Scott Dehm, PhD; Robert Turesky, BSc, PhD; Kyle Anderson, MD and Joseph Zabell, MD.
University of Minnesota Health Cancer Care – Institute for Prostate and Urologic Cancers
Thomas Griffith, PhD
Shilpa Gupta, MD, MBBS
Christopher Weight, MD
In support of improving patient care, University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.
Early Rate: On or before October 13, 2017
Other Healthcare Professional: $125
Medical Industry Professional: $200
Regular Rate: After October 14, 2017
Other Healthcare Professional: $150
Medical Industry Professional: $250
At least 3 registrations from the same group must be submitted to receive a $20 discount per person. Register each person separately online and enter group discount code 3GRP16 into the discount box during checkout. Or email the completed group registration form to email@example.com. NO refunds will be issued if a person from a group has to cancel or does not show up at the conference. Normal refund policy applies for complete group cancellations.
Special needs such as dietary restrictions, lactation room, etc. should be indicated in advance; requests cannot always be honored on site.
CPD may take photos/video of participants at CPD events and these may appear in CPD's promotional materials. Your attendance constitutes your permission and consent for photography and video subsequent usage.
Parking costs are not included in registration fees.
Front Door Access
The front door of The Commons Hotel will be under construction and out of order for the conference. Please use the entrances indicated by the blue arrows or the West Entry as noted on the map below. The map can also be accessed by clicking here.
Donald Floyd Gleason
Dr. Donald Gleason devised his scoring system in the 1960s through his observations of the cellular architecture of the prostate, the gland that produces seminal fluid. The score is considered the most reliable indicator of the potential for prostate cancer to grow and spread. It helps provide a prognosis and guide treatment, and it is a reference.
Gleason examined biopsy samples from more than 300 patients at the medical center and eventually defined five representative pictures that were characteristic of virtually all the patients. He then sent the pictures to the National Institute of Health statisticians who had all the information about the patients. These statisticians found a surprisingly strong correlation between the pictures and the patients’ death rates.
Dr. Gleason was born in Spencer, Iowa, though he grew up in Litchfield, Minnesota, where his father, Fred Gleason, ran a hardware store, and his mother, Ethel, was a schoolteacher. He attended the University of Minnesota, and received his bachelor's degree, M.D., and Ph.D. from that institution. He entered the U.S. Army Medical Corps, serving an internship at the University of Maryland, Baltimore and training as a resident in pathology at the VA hospital in Minneapolis
Dr. Gleason rose to become chief of pathology at the medical center, and also taught at the University of Minnesota, with which the center is affiliated. He retired in 1986.
In 2001, he received both the American Urological Association's Presidential Citation Award and an Outstanding Achievement Award from the University of Minnesota